• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

antibody drugs

A chessboard with blocks that read MA
Biotech

Sino Biopharm buys Merck’s PD-1xVEGF bispecific partner LaNova

LaNova's PD-1xVEGF bispecific antibody was licensed to Merck in a $588 million upfront deal.
Angus Liu Jul 15, 2025 10:16am
Court lawsuit legal litigation

Biocon accused of IP theft to create cancer biotech Bicara

Oct 24, 2024 11:04am
An artists concept of different strains or types of coronaviruses shown in multiple bright colors against a teal background

AstraZeneca preps new COVID push after antibody's ph. 3 success

May 16, 2024 7:15am
Charles River

Charles River Labs partners with Wheeler Bio for CMC platform

Feb 26, 2024 3:15pm
Disco ball dancefloor

Disco gets down with €20M to find targets for cancer therapy

Jan 16, 2024 3:30am
GlaxoSmithKline building

GSK gives early look at HIV bNAb's power

Oct 25, 2022 10:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings